June 28, 2011 | Filed under: Health,News | Posted by:
The FDA is hearing testimony from doctors and patients about whether it should reconsider a decision to withdraw approval of Avastin as a treatment for advanced breast cancer.
Posted by
on June 28, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can skip to the end and leave a response. Pinging is currently not allowed.
Posted by
on June 28, 2011. Filed under